DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
F 18 T807 ( DrugBank: - )
2 diseases
告示番号
疾患名
(ページ内リンク)
臨床試験数
2
筋萎縮性側索硬化症
1
127
前頭側頭葉変性症
1
2. 筋萎縮性側索硬化症
臨床試験数
:
645
/
薬物数
:
589
- (
DrugBank
:
163
) /
標的遺伝子数
:
150
-
標的パスウェイ数
:
225
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT02414230
(
ClinicalTrials.gov
)
February 2015
7/4/2015
F 18 T807
Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis
F 18 T807
Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis (IND 123119 Protocol B)
Amyotrophic Lateral Sclerosis (ALS)
Drug: Drug:
F 18 T807
Tammie L. S. Benzinger, MD, PhD
NULL
Completed
18 Years
N/A
All
9
United States
127. 前頭側頭葉変性症
臨床試験数
:
90
/
薬物数
:
87
- (
DrugBank
:
30
) /
標的遺伝子数
:
39
-
標的パスウェイ数
:
88
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT02707978
(
ClinicalTrials.gov
)
September 30, 2017
7/4/2015
F 18 T807
Tau PET Imaging of Frontotemporal Dementia (FTD)
F 18 T807
Tau PET Imaging of Frontotemporal Dementia
Alzheimer Disease
Drug:
F 18 T807
Tammie L. S. Benzinger, MD, PhD
NULL
Withdrawn
18 Years
N/A
All
0
Phase 2
United States